FDA — authorised 16 May 2019
- Application: ANDA211253
- Marketing authorisation holder: PERRIGO PHARMA INTL
- Status: supplemented
FDA authorised Pain Relieving on 16 May 2019
Yes. FDA authorised it on 16 May 2019.
PERRIGO PHARMA INTL holds the US marketing authorisation.